HYPERHEP B 220 [iU]/mL (Hepatitis B Immune Globulin (Human) INJECTION) 220 [iU]/mL

HyperHEP B 220 [iU]/mL is a hepatitis B immune globulin injection used for passive immunization. This product provides temporary protection against hepatitis B virus infection.

Strength

220 [iU]/mL

Pack Size

1 SYRINGE, GLASS in 1 CARTON (13533-636-02) / 1 mL in 1 SYRINGE, GLASS (13533-636-20)

Manufacturer / TM Owner

GRIFOLS USA, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

HyperHEP B 220 [iU]/mL is primarily used for passive immunization against hepatitis B virus infection. It is often administered to individuals who have been exposed to the virus, such as through accidental needle sticks or exposure to infected blood. This injection provides temporary protection and is typically used in conjunction with the hepatitis B vaccine for long-term immunity.

Side Effects

Common effects of HyperHEP B 220 [iU]/mL may include mild soreness or swelling at the injection site. Some individuals might experience temporary discomfort or redness. These effects are generally mild and resolve on their own.

Precautions & Warnings

HyperHEP B 220 [iU]/mL should be administered by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before receiving this injection. Follow all storage and handling instructions provided by the manufacturer to ensure the product's efficacy.

Avoid Interactions

HyperHEP B 220 [iU]/mL may interact with other medications or immune globulins. It is important to discuss all current medications with a healthcare provider before receiving this injection. Avoid alcohol consumption before and after administration, as it may affect the body's response.

Frequently Asked Questions

HyperHEP B 220 [iU]/mL is used for passive immunization against hepatitis B virus infection, providing temporary protection.

HyperHEP B 220 [iU]/mL is administered as an intramuscular injection by a healthcare professional.

Common side effects may include mild soreness or swelling at the injection site, which usually resolves on its own.

It is important to discuss all current medications with a healthcare provider before receiving HyperHEP B 220 [iU]/mL to avoid potential interactions.

Follow the storage instructions provided by the manufacturer to ensure the product's efficacy and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.